Recruiting Interstitial Cystitis Studies in Litchfield Park
ABTECT - Maintenance
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with m...
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating ...
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety a...
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Pa...
An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
This is an open-label, multicenter, phase 4 study in IG treatment-naïve participants with PID, conducted in the United States (US), to assess the PK, safety, and tolerability of IgPro20. The primary o...
About Interstitial Cystitis Clinical Trials in Litchfield Park
Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.
There are currently 5 interstitial cystitis clinical trials recruiting participants in Litchfield Park, AZ. These studies are seeking a combined 3,074 participants. Research is being sponsored by Abivax S.A., Celldex Therapeutics, Sanofi and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Cystitis Clinical Trials in Litchfield Park — FAQ
Are there interstitial cystitis clinical trials in Litchfield Park?
Yes, there are 5 interstitial cystitis clinical trials currently recruiting in Litchfield Park, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Litchfield Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Litchfield Park research site will contact you about next steps.
Are clinical trials in Litchfield Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Litchfield Park studies also compensate for your time and travel.
What interstitial cystitis treatments are being tested?
The 5 active trials in Litchfield Park are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.
Data updated March 2, 2026 from ClinicalTrials.gov